News on FDA’s Quality Management Maturity Program-Maturity to Continually Improve and to not be Reactive
FDA Law Blog
MARCH 1, 2023
In this report, it’s stated that 62% of drug shortages reported between 2012 and 2017 were due to quality issues which is attributed in part to a lack of recognition or reward for manufacturers with mature quality management systems that focus on continuous improvement and early detection of supply chain issues. By Holly N.
Let's personalize your content